UPDATE - Auriga Downgraded Allscripts-Misys Healthcare (MDRX) to Hold; Challenging Growth

March 29, 2012 11:14 AM EDT
Get Alerts MDRX Hot Sheet
Price: $4.97 +0.40%

Rating Summary:
    8 Buy, 19 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Auriga downgraded Allscripts-Misys Healthcare (NASDAQ: MDRX) from Buy to Hold. PT lowered from $25 to $19.

Auriga analyst said, "Data points from HIMSS and other recent events confirm that Allscripts holds a distant third place in the acute care IT market, and will be challenged to grow, while simultaneously seeing pressure in the ambulatory market from emerging cloud-based models. While we think Allscripts will capture its share of replacement business among community hospitals, it will be increasingly reliant on large deals (like SA Health) to hit its goals for double-digit revenue growth. Additionally, much work remains with respect to new leadership indoctrination, building an integrated product roadmap and restoring customer satisfaction levels."

Auriga lowers FY12/13 estimates.

To see more ratings on MDRX, Click Here


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst EPS Change, Analyst EPS View, Analyst PT Change, Downgrades

Related Entities

Auriga